vs
GRAFTECH INTERNATIONAL LTD（EAF）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
GRAFTECH INTERNATIONAL LTD的季度营收约是RIGEL PHARMACEUTICALS INC的1.7倍（$116.5M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -55.9%，领先440.0%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -13.2%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -7.7%）
格瑞泰克国际有限公司是石墨电极与石油焦生产商，其产品是电弧炉炼钢及其他金属生产的核心原材料。公司总部位于俄亥俄州布鲁克林海茨，在法国加来、西班牙潘普洛纳、墨西哥蒙特雷以及美国宾夕法尼亚州圣玛丽斯均设有生产基地。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
EAF vs RIGL — 直观对比
营收规模更大
EAF
是对方的1.7倍
$69.8M
营收增速更快
RIGL
高出34.4%
-13.2%
净利率更高
RIGL
高出440.0%
-55.9%
两年增速更快
RIGL
近两年复合增速
-7.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $116.5M | $69.8M |
| 净利润 | $-65.1M | $268.1M |
| 毛利率 | -20.9% | 91.5% |
| 营业利润率 | -33.6% | 33.2% |
| 净利率 | -55.9% | 384.0% |
| 营收同比 | -13.2% | 21.2% |
| 净利润同比 | -31.6% | 1769.2% |
| 每股收益（稀释后） | $-6.86 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EAFRIGL
| Q4 25 | $116.5M | $69.8M | ||
| Q3 25 | $144.0M | $69.5M | ||
| Q2 25 | $131.8M | $101.7M | ||
| Q1 25 | $111.8M | $53.3M | ||
| Q4 24 | $134.2M | $57.6M | ||
| Q3 24 | $130.7M | $55.3M | ||
| Q2 24 | $137.3M | $36.8M | ||
| Q1 24 | $136.6M | $29.5M |
净利润EAFRIGL
| Q4 25 | $-65.1M | $268.1M | ||
| Q3 25 | $-28.5M | $27.9M | ||
| Q2 25 | $-86.9M | $59.6M | ||
| Q1 25 | $-39.4M | $11.4M | ||
| Q4 24 | $-49.5M | $14.3M | ||
| Q3 24 | $-36.1M | $12.4M | ||
| Q2 24 | $-14.8M | $-1.0M | ||
| Q1 24 | $-30.9M | $-8.2M |
毛利率EAFRIGL
| Q4 25 | -20.9% | 91.5% | ||
| Q3 25 | 7.2% | 93.2% | ||
| Q2 25 | 0.0% | 95.6% | ||
| Q1 25 | -1.5% | 91.7% | ||
| Q4 24 | -7.8% | 89.9% | ||
| Q3 24 | -9.2% | 85.5% | ||
| Q2 24 | 2.9% | 92.4% | ||
| Q1 24 | -1.0% | 93.1% |
营业利润率EAFRIGL
| Q4 25 | -33.6% | 33.2% | ||
| Q3 25 | -3.6% | 40.9% | ||
| Q2 25 | -11.0% | 60.1% | ||
| Q1 25 | -16.3% | 23.9% | ||
| Q4 24 | -18.6% | 28.9% | ||
| Q3 24 | -20.1% | 25.4% | ||
| Q2 24 | -2.0% | 1.2% | ||
| Q1 24 | -15.6% | -23.6% |
净利率EAFRIGL
| Q4 25 | -55.9% | 384.0% | ||
| Q3 25 | -19.8% | 40.2% | ||
| Q2 25 | -65.9% | 58.6% | ||
| Q1 25 | -35.2% | 21.5% | ||
| Q4 24 | -36.9% | 24.9% | ||
| Q3 24 | -27.6% | 22.5% | ||
| Q2 24 | -10.7% | -2.8% | ||
| Q1 24 | -22.6% | -27.9% |
每股收益（稀释后）EAFRIGL
| Q4 25 | $-6.86 | $14.11 | ||
| Q3 25 | $-1.10 | $1.46 | ||
| Q2 25 | $-0.34 | $3.28 | ||
| Q1 25 | $-0.15 | $0.63 | ||
| Q4 24 | $-3.51 | $0.82 | ||
| Q3 24 | $-1.40 | $0.70 | ||
| Q2 24 | $-0.06 | $-0.06 | ||
| Q1 24 | $-0.12 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $155.0M |
| 总债务越低越好 | $1.1B | $52.5M |
| 股东权益账面价值 | $-259.6M | $391.5M |
| 总资产 | $1.0B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资EAFRIGL
| Q4 25 | — | $155.0M | ||
| Q3 25 | — | $137.1M | ||
| Q2 25 | — | $108.4M | ||
| Q1 25 | — | $77.1M | ||
| Q4 24 | — | $77.3M | ||
| Q3 24 | — | $61.1M | ||
| Q2 24 | $120.7M | $49.1M | ||
| Q1 24 | $165.2M | $49.5M |
总债务EAFRIGL
| Q4 25 | $1.1B | $52.5M | ||
| Q3 25 | $1.1B | $60.0M | ||
| Q2 25 | $1.1B | $60.0M | ||
| Q1 25 | $1.1B | $60.0M | ||
| Q4 24 | $1.1B | $60.0M | ||
| Q3 24 | $929.5M | $60.0M | ||
| Q2 24 | $928.2M | $60.0M | ||
| Q1 24 | $926.9M | $60.0M |
股东权益EAFRIGL
| Q4 25 | $-259.6M | $391.5M | ||
| Q3 25 | $-194.4M | $117.6M | ||
| Q2 25 | $-168.4M | $81.9M | ||
| Q1 25 | $-105.3M | $18.6M | ||
| Q4 24 | $-78.9M | $3.3M | ||
| Q3 24 | $-9.0M | $-14.6M | ||
| Q2 24 | $16.2M | $-29.9M | ||
| Q1 24 | $37.6M | $-31.7M |
总资产EAFRIGL
| Q4 25 | $1.0B | $513.6M | ||
| Q3 25 | $1.1B | $242.5M | ||
| Q2 25 | $1.1B | $206.7M | ||
| Q1 25 | $1.2B | $176.0M | ||
| Q4 24 | $1.2B | $164.0M | ||
| Q3 24 | $1.1B | $139.4M | ||
| Q2 24 | $1.2B | $128.4M | ||
| Q1 24 | $1.2B | $126.5M |
负债/权益比EAFRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | 57.16× | — | ||
| Q1 24 | 24.64× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-20.9M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $-39.3M | — |
| 自由现金流率自由现金流/营收 | -33.7% | — |
| 资本支出强度资本支出/营收 | 15.8% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $-120.5M | — |
8季度趋势，按日历期对齐
经营现金流EAFRIGL
| Q4 25 | $-20.9M | $22.0M | ||
| Q3 25 | $24.7M | $24.0M | ||
| Q2 25 | $-53.2M | $30.5M | ||
| Q1 25 | $-32.2M | $-893.0K | ||
| Q4 24 | $-26.4M | $14.5M | ||
| Q3 24 | $23.7M | $21.7M | ||
| Q2 24 | $-36.9M | $302.0K | ||
| Q1 24 | $-530.0K | $-5.0M |
自由现金流EAFRIGL
| Q4 25 | $-39.3M | — | ||
| Q3 25 | $18.4M | — | ||
| Q2 25 | $-57.1M | — | ||
| Q1 25 | $-42.5M | — | ||
| Q4 24 | $-39.2M | — | ||
| Q3 24 | $19.7M | — | ||
| Q2 24 | $-43.8M | — | ||
| Q1 24 | $-11.0M | — |
自由现金流率EAFRIGL
| Q4 25 | -33.7% | — | ||
| Q3 25 | 12.8% | — | ||
| Q2 25 | -43.3% | — | ||
| Q1 25 | -38.0% | — | ||
| Q4 24 | -29.2% | — | ||
| Q3 24 | 15.1% | — | ||
| Q2 24 | -31.9% | — | ||
| Q1 24 | -8.1% | — |
资本支出强度EAFRIGL
| Q4 25 | 15.8% | — | ||
| Q3 25 | 4.4% | — | ||
| Q2 25 | 3.0% | — | ||
| Q1 25 | 9.2% | — | ||
| Q4 24 | 9.5% | — | ||
| Q3 24 | 3.1% | — | ||
| Q2 24 | 5.1% | — | ||
| Q1 24 | 7.7% | — |
现金转化率EAFRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EAF
| Graphite Electrodes | $107.0M | 92% |
| By Products And Other | $9.4M | 8% |
RIGL
暂无分部数据
